Open AccessP1133: SUB‐CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW‐TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY.
Author(s) -
Cartron G.,
Bachy E.,
Tilly H.,
Daguindau N.,
Pica G.M.,
Bijou F.,
Mounier C.,
Clavert A. M.,
Damaj G. L.,
Slama B.,
Casasnovas O.,
Houot R.,
Bouabdallah K.,
Sibon D.,
Fitoussi O.,
Morineau N.,
Herbaux C.,
Gastinne T.,
Fornecker L.M.,
Haioun C.,
Launay V.,
Araujo C.,
Benbrahim O.,
Sanhes L.,
Gressin R.,
Gonzalez H.,
Morschhauser F.,
Xerri L.,
Tarte K.,
Pranger D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847400.79465.e8
Subject(s) - rituximab , medicine , follicular lymphoma , clinical endpoint , progression free survival , lymphoma , population , maintenance therapy , phases of clinical research , surgery , oncology , gastroenterology , randomized controlled trial , clinical trial , chemotherapy , environmental health